RQM+ RQM+ is the world’s leading provider of regulatory, clinical and quality solutions to the MedTech industry. For more information, visit www.RQMplus.com.

Learn more at www.RQMplus.com

Find us on LinkedIn at https://www.linkedin.com/company/rqmplus RQM+ is the leading MedTech service provider with the world’s largest global team of regulatory and quality experts. We provide comprehensive regulatory, quality, reimbursement, clinical and laboratory services, supporting market access throughout the entire product lifecycle for medical devices and diagnostics. With more former FDA, MHRA and notified body regulators than any other firm, the RQM+ team has deep expertise in all clinical specialties. RQM+ currently works for eight of the top 10 medical device manufacturers and seven of the top 10 IVD companies.

Let's Talk About Women's Health: Thyroid Dysfunction
03/12/2025

Let's Talk About Women's Health: Thyroid Dysfunction

Victoria Chester Rose shares her journey with hypothyroidism, emphasizing the need for advocacy in women's health and the role of MedTech in early diagnosis and treatment.

Let's Talk About Women's Health: Diabetes
03/05/2025

Let's Talk About Women's Health: Diabetes

Meghann Peters shares her journey with type 1 diabetes, highlighting the transformative impact of MedTech advancements on managing the disease.

Ensuring Compliance with FDA’s Final Rule for Laboratory Developed Tests (LDTs)
02/24/2025

Ensuring Compliance with FDA’s Final Rule for Laboratory Developed Tests (LDTs)

Navigate FDA’s LDT final rule with RQM+’s strategic approach, ensuring compliance, minimizing disruptions, and meeting key milestones for market access.

Code Red: How Reimbursement Fails MedTech’s Best and Brightest
02/20/2025

Code Red: How Reimbursement Fails MedTech’s Best and Brightest

Struggling with MedTech reimbursement? Learn how RQM+ helps innovators break through regulatory hurdles, secure coverage, and bring life-saving devices to market.

Hearts in a Bind: Choosing Between Promise and Predictability
02/14/2025

Hearts in a Bind: Choosing Between Promise and Predictability

TAVR transforms heart care with a less invasive approach, but does it last? Explore durability data, patient risks, and the future of valve innovation.

Tricuspid Brinkmanship: Are We Overhyping the Right-Sided Revolution?
02/10/2025

Tricuspid Brinkmanship: Are We Overhyping the Right-Sided Revolution?

Are tricuspid valve interventions a breakthrough or overhyped? Explore the balance between innovation, clinical realities, and patient outcomes in the evolving right-sided revolution.

MitraClip and the Business of American Healthcare: Innovation, Inefficiency, and the Cost of Care
02/04/2025

MitraClip and the Business of American Healthcare: Innovation, Inefficiency, and the Cost of Care

Exploring the MitraClip: a medical innovation under scrutiny for its varied effectiveness, high costs, and the influence of industry forces on healthcare priorities.

One Year Countdown: Preparing for the FDA's QMSR Implementation
02/03/2025

One Year Countdown: Preparing for the FDA's QMSR Implementation

The FDA's QMSR takes effect in one year. Ensure compliance by aligning with ISO 13485:2016 now. Key steps: gap assessment, training, and audits.

Stick or Twist? 2025 Is a Big Year for ISO 13485
01/28/2025

Stick or Twist? 2025 Is a Big Year for ISO 13485

Explore the 2025 ISO 13485:2016 review, its industry impact, key survey insights, and how MedTech professionals can influence its future.

Beyond Inclusion: Reimagining Equity and Real-World Impact in Heart Failure Trials
12/18/2024

Beyond Inclusion: Reimagining Equity and Real-World Impact in Heart Failure Trials

Discover new approaches to HF trials that go beyond inclusion, reimagining equity and real-world impact for improved patient outcomes.

Redefining HFpEF Care: Precision Therapies for an Inclusive Future
12/09/2024

Redefining HFpEF Care: Precision Therapies for an Inclusive Future

Explore the latest insights on tricuspid regurgitation, including advanced imaging, TTVI therapies, and tailored strategies for improved patient outcomes.

Tricuspid Regurgitation: State-of-the-Art Insights
12/02/2024

Tricuspid Regurgitation: State-of-the-Art Insights

Explore the latest insights on tricuspid regurgitation, including advanced imaging, TTVI therapies, and tailored strategies for improved patient outcomes.

Address

2790 Mosside Blvd
Monroeville, PA
15146

Alerts

Be the first to know and let us send you an email when RQM+ posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to RQM+:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram